Alfaroastatin Calcium Tablet 5 mg
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Alpha Pharmaceutical Co., Ltd.
MFDS item code 201903274 · Approved 2019.05.21
This product's status changed to Expired on 2024.05.21. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of dyslipidemia, reduction of cardiovascular disease risk, and inhibition of atherosclerosis progression
This medication is used to treat various forms of hypercholesterolemia and dyslipidemia. It is mainly used as an adjunct to dietary changes and exercise in cases of difficult-to-control primary hypercholesterolemia or mixed hyperlipidemia. In severe cases, it can be used in patients with homozygous familial hypercholesterolemia alongside diet or other treatments to lower cholesterol levels. Additionally, it is administered as an adjunct to diet in children aged 10 to 17 years with familial hypercholesterolemia. It lowers total cholesterol and LDL cholesterol in patients with hypercholesterolemia, thereby delaying the progression of atherosclerosis, and is also beneficial for patients with primary dysbetalipoproteinemia. Furthermore, it helps reduce the risk of stroke, myocardial infarction, and arterial revascularization in high-risk patients with cardiovascular disease risk factors. Therefore, this medication is used to improve hypercholesterolemia and cardiovascular disease risk.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia The initial dose is 5 mg once daily, and the dose may be adjusted to a maintenance dose if a greater reduction in LDL-cholesterol is required. The maintenance dose is 10 mg once daily, which controls the condition in most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or more according to LDL-cholesterol levels, treatment goals, and patient response, and may be increased up to a maximum of 20 mg once daily. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering this drug at a dose of 20 mg to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this drug to patients with active liver disease. 6. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dose range is 5 mg to 20 mg once daily. (There are no clinical data on doses higher than 20 mg in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or more. Under 10 years of age: Safety and efficacy have not been established.
This medication should not be administered to certain patients. For example, it should not be used in patients with allergies to this drug, severe liver dysfunction, myopathy, severe kidney dysfunction, or women who are pregnant or breastfeeding. This drug can affect the liver and muscles; therefore, patients with a history of liver disease or those who consume excessive alcohol should undergo liver function tests before administration and be cautious. Additionally, if symptoms of muscle pain or weakness occur, they should immediately consult a doctor. This medication can interact with other drugs, so patients must inform their healthcare provider about any other medications they are taking, especially with fibrate-class medications, which require caution when used in combination. Women who could become pregnant should use appropriate contraception while taking this medication and avoid its use during pregnancy or breastfeeding. Routine liver function and muscle-related tests are recommended while taking this drug, and special caution is warranted for elderly patients or those with decreased kidney function. In the case of overdose, there is no specific antidote, so patients should seek medical help immediately for appropriate treatment and monitoring. Caution is needed while driving or operating machinery, as dizziness may occur. This medication contains lactose, so it is advised that patients with lactose intolerance avoid taking it. Finally, this medication may rarely cause serious skin reactions, liver damage, or neurological abnormalities, and any unusual symptoms should be reported to healthcare staff immediately.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ophthalmoplegia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome, lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, increased CK, increased AST, joint pain, fatigue, numbness, paresthesia, discomfort in the chest, anorexia, abdominal distension, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, acute renal failure, oliguria, increased serum creatinine
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. Additionally, it is best to store it at room temperature, specifically between 1 to 30 degrees Celsius.
Yellow round film-coated tablets
28 tablets (14 tablets/PTPX2) - 14 tablets/PTP, 28 tablets (14 tablets/PTPX2) - 2 PTP/box
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Alpha Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.